News Focus Channel: Cancer Center Featured Story 2

Disparities Narrowing Among Patients Undergoing Blood Stem Cell Transplant, Roswell Park Study Reveals

Roswell Park Comprehensive Cancer Center — Fri, 20 Sep 2024 10:05:15 EST

Open Disparities Narrowing Among Patients Undergoing Blood Stem Cell Transplant, Roswell Park Study Reveals configuration options Historically, some patients with blood cancers have been less likely than others to receive stem cell transplant, also known as bone marrow transplant.

MD Anderson Research Highlights for September 19, 2024

University of Texas MD Anderson Cancer Center — Thu, 19 Sep 2024 12:00:52 EST

The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

MSK Research Highlights September 18, 2024

Memorial Sloan Kettering Cancer Center — Wed, 18 Sep 2024 11:05:31 EST

New research from Memorial Sloan Kettering Cancer Center (MSK) uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available contrast dye could help surgeons better separate cancer from healthy tissue.

Novel Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia

University of Texas MD Anderson Cancer Center — Tue, 17 Sep 2024 18:30:00 EST

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) - including both accelerated or myeloid blast phases of the disease - or Philadelphia chromosome-positive acute myeloid leukemia (AML) achieved a bone marrow remission when treated with a novel combination of decitabine, venetoclax and ponatinib.

Advanced 3D Mammography Detects More Breast Cancers, Fewer False Positives

Yale Cancer Center/Smilow Cancer Hospital — Tue, 17 Sep 2024 11:05:06 EST

The newer, 3D form of breast screening, known as digital breast tomosynthesis (DBT), is more effective at detecting breast cancer than traditional 2D digital mammography (DM). That's the conclusion of an analysis of 13 years' worth of screening data conducted by Yale Cancer Center researchers.

Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma

Roswell Park Comprehensive Cancer Center — Tue, 17 Sep 2024 10:05:33 EST

A significant number of multiple myeloma patients may have an inherited but previously unrecognized risk of developing the disease, a new study led by Roswell Park Chief of Clinical Genomics Kenan Onel, MD, PhD, reveals.

New Tumor Models Provide Insights Into Deadly Sarcomas

UC Davis Health — Mon, 16 Sep 2024 13:05:33 EST

Researchers at UC Davis and UCLA have created models for four sarcoma subtypes using stem cells. The findings may lead to new therapies.

Roswell Park-Designed Treatment Regimen Doubles Progression-Free Survival in Metastatic Kidney Cancer

Roswell Park Comprehensive Cancer Center — Sun, 15 Sep 2024 11:05:00 EST

During the European Society for Medical Oncology (ESMO) Congress, Saby George, MD, FACP, of Roswell Park Comprehensive Cancer Center presented findings on a novel two-agent treatment that more than doubled progression-free survival compared with single-agent treatment.

ESMO: Combination Therapy Reduced Agitated Delirium in Patients with Advanced Cancers

University of Texas MD Anderson Cancer Center — Sat, 14 Sep 2024 09:45:00 EST

Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.

Antibody-Drug Conjugate Found Effective Against Brain Metastases in Patients with HER2-Positive Breast Cancer

Dana-Farber Cancer Institute — Fri, 13 Sep 2024 11:05:28 EST

A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with advanced HER2-positive breast cancer. Research led by Dana-Farber Cancer Institute.

Repeat Immune Checkpoint Inhibitor Therapy Not Recommended for Advanced Kidney Cancer

Dana-Farber Cancer Institute — Fri, 13 Sep 2024 10:05:02 EST

In an international multicenter randomized phase 3 clinical trial led by Dana-Farber Cancer Institute, researchers tested the addition of the immune checkpoint inhibitor (ICI) nivolumab to treatment with tivozanib for patients with advanced clear cell renal cell carcinoma.

ESMO: Novel ADC AZD8205 Demonstrates Manageable Safety Profile and Preliminary Efficacy in First-in-Human Trial

University of Texas MD Anderson Cancer Center — Fri, 13 Sep 2024 09:05:13 EST

The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial efficacy in heavily pretreated patients with advanced or metastatic solid tumors, according to interim data shared today at the 2024 European Society for Medical Oncology (ESMO) Congress by researchers from The University of Texas MD Anderson Cancer Center.

Residents in San Joaquin Valley Breathe Chemical Pesticides, According to New Study

UC Davis Health — Thu, 12 Sep 2024 17:05:23 EST

A UC Davis Health study found 22% of adults and 10% of children who participated in an air-quality study in California's San Joaquin Valley were breathing detectable levels of pesticides.

NCCN Commits to Sharing Award-Winning Resources for People with Cancer in Spanish and Other Languages

National Comprehensive Cancer Network(r) (NCCN(r)) — Thu, 12 Sep 2024 08:55:29 EST

The National Comprehensive Cancer Network (NCCN) and the NCCN Foundation announce plans to make every book in the library of NCCN Guidelines for Patients available in Spanish; with select editions available in additional languages as well.

New, Rare Type of Small Cell Lung Cancer Identified by MSK Research Team

Memorial Sloan Kettering Cancer Center — Wed, 11 Sep 2024 15:05:40 EST

A team of doctors and researchers at MSK have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked. Learn how one 19-year-old patient sparked a detective story.

Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024

Dana-Farber Cancer Institute — Wed, 11 Sep 2024 08:35:00 EST

Novel treatments, including targeted therapies and antibody drug conjugates, as well as research into improving quality of life for patients with breast cancer, headline studies led by Dana-Farber Cancer Institute and presented at the European Society of Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain.

NCCN Policy Summit Explores how to Build an Inclusive Cancer Center Workplace Culture that Better Serves Everybody

National Comprehensive Cancer Network(r) (NCCN(r)) — Tue, 10 Sep 2024 14:00:57 EST

Speakers at an NCCN Oncology Policy Summit discuss the importance of diversity, equity, and inclusion (DEI) as integral to the oncology workforce to improve cancer outcomes, and what to do about backlash.

MD Anderson Research Highlights Special Edition: ESMO 2024

University of Texas MD Anderson Cancer Center — Tue, 10 Sep 2024 10:00:01 EST

The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.

Mark Awad Named Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center — Tue, 10 Sep 2024 09:00:00 EST

Mark Awad, MD, PhD, has been appointed Chief of the Thoracic Oncology Service within the Solid Tumor Oncology Division, Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).

MD Anderson Research Highlights Special Edition: 2024 World Conference on Lung Cancer

University of Texas MD Anderson Cancer Center — Mon, 09 Sep 2024 14:05:55 EST

The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. This special edition features compelling data on lung cancer advances presented by MD Anderson researchers at the 2024 World Conference on Lung Cancer.